Putnam Investments LLC Agios Pharmaceuticals, Inc. Transaction History

Putnam Investments LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$30.08 - $50.59 $2.93 Million - $4.93 Million	-97,500 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$32.4 - $49.58 $3.16 Million - $4.83 Million	97,500 New	97,500 $3.16 Million
Q1 2018 May 15, 2018	SELL	$59.83 - $86.53 $13.6 Million - $19.7 Million	-227,350 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$52.12 - $72.33 $11 Million - $15.3 Million	211,727 Added 1355.23%	227,350 $13 Million
Q3 2017 Nov 14, 2017	BUY	$54.89 - $67.12 $857,546 - $1.05 Million	15,623	15,623 $1.04 Million

232

58.1M

403K

469K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $3.22B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Putnam Investments LLC with notifications on news.